What’s Next? Five Things To Look Out For In January

Humira’s US LOE Finally Arrives And Key Appointments Shape Industry

 
• By Dean Rudge

The biggest loss of exclusivity in pharmaceutical history is set to steal headlines in the first month of 2023, as Teva begins a new year with a new CEO.

What's Next Image
The biggest developments to come in January 2023 • Source: Citeline

More from Biosimilars

More from Products